The acquisition of SynGen closed on July 07, 2017, prior to which, the Cesca contributed the assets of its blood and bone-marrow processing device business to ThermoGenesis. Cesca, post the ...
Bay City Capital has invested in SynGen, Inc., which focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone ...
SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and ...
Explore the TWO:8279 financials. Find the Syngen Biotech financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...
Regenerative medicine device company SynGen has completed a $5 million Series A preferred stock financing with Bay City Capital. Under the terms of the transaction, BCC will appoint two ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sacramento medical device startup SynGen Inc. has gotten $2 ...
Cesca Therapeutics Inc. shares surged 11% in premarket trade Monday, after the provider of automated cell processing and point-of-care, autologous cell-based therapies said its wholly-owned unit ...
SACRAMENTO, Calif., Nov. 30, 2014 /PRNewswire/ -- SynGen Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Regenerative medicine company SynGen says it has hired ...
Syngen Biotech (TWO:8279) Annual Report This summary provides an overview of the most significant critical numbers from each of the Syngen Biotech financial reports, including the Syngen Biotech Co ...
Syngen Biotech Co., Ltd. engages in the manufacture and sale of microbial pharmaceutical and Biochemical Nutrition. It specializes in strain identification, micro-organism fermentation, recovery, and ...
Syngen Biotech Co Ltd Company Profile Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results